ESPR
Esperion Therapeutics Inc
NASDAQ · Pharmaceuticals
$3.40
+0.22 (+6.92%)
Open$3.25
Previous Close$3.18
Day High$3.45
Day Low$3.22
52W High$4.18
52W Low$0.69
Volume—
Avg Volume4.62M
Market Cap812.82M
P/E Ratio—
EPS$-0.54
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+456.2% upside
Current
$3.40
$3.40
Target
$18.91
$18.91
$12.50
$18.91 avg
$21.23
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 424.43M | 262.25M | 131.25M |
| Net Income | -66,077,135 | -36,745,811 | 36.94M |
| Profit Margin | -15.6% | -14.8% | 28.2% |
| EBITDA | -47,812 | -28,065 | 70.25M |
| Free Cash Flow | — | — | 44.11M |
| Rev Growth | +61.8% | +61.8% | -8.2% |
| Debt/Equity | — | — | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |